Breaking News
Monday , August 21 2017
Home / Tag Archives: MDD

Tag Archives: MDD

Suven Life Sciences initiates Phase 1 clinical trial of SUVN-911

Suven Life Sciences’ NCESUVN-911, a potent, selective, brain penetrant and orally active, novel chemical entity intended for the treatment of major depressive disorder (MDD) has initiated Phase 1 development and first dosing under US IND 133850 and the topline results from the study is expected during the quarter Jan-March 2018. ... Read More »

Yoga may help combat depression: study

Participating in yoga and deep breathing classes twice a week along with home practice may effectively reduce the symptoms of depression, a new study claims. The findings provide support for the use of yoga-based interventions as an alternative or supplement to pharmacologic treatments for depression, researchers said. “This study supports ... Read More »

Close